StreetInsider.com News Articles

Cosmos Health expands Albania distribution deal to 54,000 annual units

Mon, 20 Jul 2026 15:58:33 -0400

Cosmos Health Inc. (NASDAQ: COSM) announced an expansion of its distribution partnership with Pharma Cell for its Sky Premium Life brand in Albania, according to a company press release.

The companies originally launched their partnership in April 2025. Under the expanded arrangement, average monthly orders have already exceeded 4,500 units, with annualized orders projected to surpass 54,000 units. The projection is forward-looking and subject to risks outlined by the company.

Pharma Cell, based in Tirana, distributes the Sky Premium Life products through pharmacies and to healthcare professionals across Albania.

Greg Siokas, CEO of Cosmos Health, said: "The growth of our partnership with Pharma

Cosmos Health Expands Pharma Cell Partnership in Albania with Annualized Orders Projected to Exceed 54,000 Units

Mon, 20 Jul 2026 15:46:00 -0400

Cosmos Health expands its Sky Premium Life partnership with Pharma Cell in Albania, with average monthly orders already exceeding 4,500 units, and projected to exceed 54,000 annually
Products are distributed across Albania and recommended by doctors and healthcare professionals, supporting broad consumer access
Expansion builds on the partnership launched in April 2025 and reflects Sky Premium Life's continued global growth

CHICAGO, July 20, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced an expansion

Cosmos Health Expands Pharma Cell Partnership in Albania with Annualized Orders Projected to Exceed 54,000 Units

Mon, 20 Jul 2026 15:46:00 -0400

Cosmos Health expands its Sky Premium Life partnership with Pharma Cell in Albania, with average monthly orders already exceeding 4,500 units, and projected to exceed 54,000 annually
Products are distributed across Albania and recommended by doctors and healthcare professionals, supporting broad consumer access
Expansion builds on the partnership launched in April 2025 and reflects Sky Premium Life's continued global growth

Cosmos Health Expands Pharma Cell Partnership in Albania with Annualized Orders Projected to Exceed 54,000 Units

Mon, 20 Jul 2026 15:46:00 -0400

Cosmos Health expands its Sky Premium Life partnership with Pharma Cell in Albania, with average monthly orders already exceeding 4,500 units, and projected to exceed 54,000 annually
Products are distributed across Albania and recommended by doctors and healthcare professionals, supporting broad consumer access
Expansion builds on the partnership launched in April 2025 and reflects Sky Premium Life's continued global growth

Cosmos Health Expands Pharma Cell Partnership in Albania with Annualized Orders Projected to Exceed 54,000 Units

Mon, 20 Jul 2026 15:46:00 -0400

Cosmos Health expands its Sky Premium Life partnership with Pharma Cell in Albania, with average monthly orders already exceeding 4,500 units, and projected to exceed 54,000 annually
Products are distributed across Albania and recommended by doctors and healthcare professionals, supporting broad consumer access
Expansion builds on the partnership launched in April 2025 and reflects Sky Premium Life's continued global growth

Form S-8 Cosmos Health Inc.

Fri, 17 Jul 2026 17:17:00 -0400

si-local-file:///var/storage/secattach/20260717/26785174.html

Form S-8 Cosmos Health Inc.

Fri, 17 Jul 2026 17:17:00 -0400

si-local-file:///var/storage/secattach/20260717/26785174.html

Cosmos Health buyback reaches 5.11 million shares at avg $0.2554

Fri, 17 Jul 2026 14:55:09 -0400

Cosmos Health Inc. (NASDAQ: COSM) announced it has repurchased an additional 274,000 shares of its common stock in the open market at an average price of approximately $0.2554 per share.

The company has now repurchased a total of 5,112,000 shares for approximately $1.11 million under its previously announced share repurchase program, which authorizes buybacks of up to $5 million. Shares may be repurchased in the open market, through privately negotiated transactions, or through other permitted means, in accordance with SEC Rules 10b5-1 and 10b-18.

The program is set to expire on December 31, 2026, and may be renewed at the company's discretion.

Cosmos Health Share Buyback Expands to 5.11 Million Shares; Continues Open Market Repurchases

Fri, 17 Jul 2026 14:55:00 -0400

CHICAGO, July 17, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 274,000 shares of its common stock in the open market at an average price of approximately $0.2554 per share.

The Company has now repurchased a total of 5,112,000 shares for approximately $1.11 million under its previously announced share repurchase program of up to $5 million. Under the program, Cosmos Health may repurchase shares from time to time in

Cosmos Health Share Buyback Expands to 5.11 Million Shares; Continues Open Market Repurchases

Fri, 17 Jul 2026 14:55:00 -0400

Cosmos Health Share Buyback Expands to 5.11 Million Shares; Continues Open Market Repurchases

Fri, 17 Jul 2026 14:55:00 -0400

Cosmos Health Share Buyback Expands to 5.11 Million Shares; Continues Open Market Repurchases

Fri, 17 Jul 2026 14:55:00 -0400

Form 8-K Cosmos Health Inc. For: Jul 15

Thu, 16 Jul 2026 16:35:00 -0400

si-local-file:///var/storage/secattach/20260716/26780146.html

Form 8-K Cosmos Health Inc. For: Jul 15

Thu, 16 Jul 2026 16:35:00 -0400

si-local-file:///var/storage/secattach/20260716/26780146.html

Cosmos Health buyback tops $1M with 4.84 million shares repurchased

Thu, 16 Jul 2026 13:15:12 -0400

Cosmos Health Inc. (NASDAQ: COSM) announced it has repurchased an additional 250,000 shares of its common stock in the open market at an average price of approximately $0.2782 per share.

The company has now repurchased a total of 4,838,000 shares for approximately $1.04 million under its share repurchase program, which authorizes buybacks of up to $5 million. The program permits repurchases in the open market, through privately negotiated transactions, or through other permitted means, in accordance with SEC Rules 10b5-1 and 10b-18.

The program is set to expire on December 31, 2026, and may be renewed at the company's discretion. Cosmos Health

Cosmos Health Share Buyback Surpasses $1 Million, Reaching 4.84 Million Shares; Continues Open Market Repurchases

Thu, 16 Jul 2026 13:15:00 -0400

CHICAGO, July 16, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 250,000 shares of its common stock in the open market at an average price of approximately $0.2782 per share.

The Company has now repurchased a total of 4,838,000 shares for approximately $1.04 million under its previously announced share repurchase program of up to $5 million. Under the program, Cosmos Health may repurchase shares from time to time in the open market,

Cosmos Health Share Buyback Surpasses $1 Million, Reaching 4.84 Million Shares; Continues Open Market Repurchases

Thu, 16 Jul 2026 13:15:00 -0400

Cosmos Health Share Buyback Surpasses $1 Million, Reaching 4.84 Million Shares; Continues Open Market Repurchases

Thu, 16 Jul 2026 13:15:00 -0400

Cosmos Health Share Buyback Surpasses $1 Million, Reaching 4.84 Million Shares; Continues Open Market Repurchases

Thu, 16 Jul 2026 13:15:00 -0400

Cosmos Health buyback tops 4.5 million shares at roughly $0.29 each

Wed, 15 Jul 2026 14:15:11 -0400

Cosmos Health Inc. (NASDAQ: COSM) has repurchased an additional 100,000 shares of its common stock in the open market at an average price of approximately $0.2928 per share, according to a press release.

The company has now repurchased a cumulative total of 4,588,000 shares for approximately $970,000 under its previously announced share repurchase program, which authorizes buybacks of up to $5 million.

Under the program, Cosmos Health may repurchase shares in the open market, through privately negotiated transactions, or through other permitted means, in accordance with SEC Rules 10b5-1 and 10b-18. The program is set to expire on December 31, 2026, and

Cosmos Health Share Buyback Surpasses 4.5 Million Shares; Continues Open Market Repurchases

Wed, 15 Jul 2026 14:15:00 -0400

CHICAGO, July 15, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has repurchased an additional 100,000 shares of its common stock in the open market at an average price of approximately $0.2928 per share.

The Company has now repurchased a total of 4,588,000 shares for approximately $970,000 under its previously announced share repurchase program of up to $5 million. Under the program, Cosmos Health may repurchase shares from time to time in the open market,

Cosmos Health Share Buyback Surpasses 4.5 Million Shares; Continues Open Market Repurchases

Wed, 15 Jul 2026 14:15:00 -0400

Cosmos Health Share Buyback Surpasses 4.5 Million Shares; Continues Open Market Repurchases

Wed, 15 Jul 2026 14:15:00 -0400

Cosmos Health Share Buyback Surpasses 4.5 Million Shares; Continues Open Market Repurchases

Wed, 15 Jul 2026 14:15:00 -0400

Cosmos Health buyback reaches 4.49M shares at $941K spent

Tue, 14 Jul 2026 14:40:10 -0400

Cosmos Health Inc. (NASDAQ: COSM) has repurchased an additional 133,000 shares of its common stock in the open market at an average price of approximately $0.298 per share, according to a press release from the company.

The company has now repurchased a total of approximately 4,488,000 shares for approximately $941,000 under its share repurchase program, which authorizes buybacks of up to $5 million. Repurchases may be conducted in the open market, through privately negotiated transactions, or through other permitted means, in accordance with SEC Rules 10b5-1 and 10b-18.

The program is set to expire on December 31, 2026, and may be renewed